The tumor-targeting ability of hIMB1636-LDP was subsequently evaluated using mouse xenograft models bearing the HCC827 or MDA-MB-468 cells, and the fluorescence signal was clearly visualized in the tumor sites within 6 h after i.v. administration of DyLight 680-labeled hIMB1636-LDP. The gene discussed is CPQ; the disease is neoplasm.